Despite the change in leadership, the three stepping down will remain involved with the firm as board members or observers, aligning their shareholding for the long term.
Indian online pharmacy PharmEasy’s valuation now stands at about $456 million, according to disclosures from its investor Janus Henderson, a 92% drop from its peak valuation of $5.6 billion.
From high hopes of an INR 6,250 Cr IPO to its current beleaguered state — PharmEasy’s fortunes have swung wildly in less than a year Inc42 has learnt that the company has reduced its workforce ...
As six-year-old tech unicorn PharmEasy acquires publicly-listed diagnostics chain Thyrocare, many believe it is a pivotal moment for startups in India CEO Siddharth Shah says the strong bond ...
Siddharth Shah, chief executive officer (CEO) and managing director (MD) of PharmEasy has also invested in the new venture in his personal capacity ...
Bengaluru: Healthtech startup PharmEasy on Monday said its co-founders Dharmil Sheth, Dhaval Shah, and Hardik Dedhia are expected to take a back seat from the day-to-day operations of the company ...
PharmEasy is redefining healthcare delivery in India. In the inaugural episode of the Masters of CX - Season 3, CEO Siddharth Shah reveals how the company leverages technology to overcome geographical ...
PharmEasy plans to raise ₹ 6,250 crore through its public issue. The company will use this capital to acquire new businesses and repay loans. Its consolidated revenue tripled to ₹2360 crore in ...
Dhaval Shah, Dharmil Sheth, and Hardhik Dedhia, the founders of API Holding, which operates PharmEasy, are preparing to launch a new venture in the consumer space. Siddharth Shah, the CEO and MD ...
From L to R: Siddharth Shah, Harsh Parekh, Dharmil Sheth, Dhaval Shah, Hardik Dedhia, Co-founders of PharmEasy | Photo Credit: Partha Pratim Sharma@Delhi Healthtech unicorn PharmEasy’s co ...
The dangerous partnership between Swiggy Instamart and PharmEasy bypasses all professional practice and treats medicine dispensing as a fast delivery model like FMCG DELIVERY. Chapter IV of section ...
PharmEasy’s board will discuss the company’s strategy for an IPO in a meeting next month and Macquarie Asset Management has restarted the process to sell its Indian renewable energy platform, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results